OECD Home › Directorate for Employment, Labour and Social Affairs › Health policies and data › Latest Documents
This seventh edition of Health at a Glance provides the latest comparable data on different aspects of the performance of health systems in OECD countries.
English, PDF, 5,674kb
This brochure presents the OECD Work on Health for 2013-2014, including all recent and forthcoming major publications and databases.
Earlier detection and better treatment for cancer would cut death rates from the disease by around a third, saving the lives of nearly a million people in the developed world every year, according to a new report by the OECD prepared with the support of the European Commission, building on earlier World Health Organisation research.
To help inform the Conference on Managing Hospital Volumes, co-organised by the German Federal Ministry of Health and the OECD, and held on the 11th April 2013 in Berlin, the OECD Secretariat produced a paper to provide an international perspective on Germany’s situation and the current policy debate.
Quarterly news on Health Issues from the OECD, including recent work on value in pharmaceutical pricing and on public health and genomics, as well as recent articles and events on health from the OECD, and information on forthcoming publications such as Health at Glance 2013 and the latest publication on Cancer Care, Working papers on Managing hospital volumes, alcohol consumption and the role of fiscal policies in health promotion.
English, PDF, 108kb
The future of public health: policy decisions today for tomorrow’s populations. Our health, our economy, our society, our future: a Brave New World. Remarks by Yves Leterme, Deputy Secretary-General, OECD. Brussels, Belgium, September 4th 2013.
The OECD/Korea Policy Centre fosters the exchange of technical information and policy experiences relating to the Asia Pacific region in areas such as health statistics, pension reforms and social policy and expenditure.
English, PDF, 1,115kb
Experience from the substantial health gains of the 20th century suggests that spending on prevention could be an important factor. Therefore, gathering data on such spending that are consistent and comparable, both over time and across countries, is potentially very useful. This paper aims to help clarify what should be included as spending on prevention under SHA 2011 to facilitate accurate comparisons.
The objective of this study is to describe how OECD Member Countries refer to value when making decisions on reimbursement and prices of new medicines.
After falling sharply in 2010, health spending remained flat across OECD countries in 2011 as the economic crisis continued to have an impact, particularly in those European countries hardest hit by the crisis, according to OECD Health Data 2013.